Lead Product(s) : Emodepside
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Swiss TPH
Deal Size : Undisclosed
Deal Type : Partnership
Bayer and Swiss TPH to Develop Treatment Against Soil-Transmitted Helminths
Details : The partnership aims to jointly develop emodepside, an anthelmintic substance that is effective against several gastrointestinal nematodes in domestic animals, in the clinical development for treating humans infected with soil-transmitted helminths.
Brand Name : BAY 44-4400
Molecule Type : Peptide
Upfront Cash : Undisclosed
July 20, 2023
Lead Product(s) : Emodepside
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Swiss TPH
Deal Size : Undisclosed
Deal Type : Partnership
LOOKING FOR A SUPPLIER?